Improved exposure of the hypoglossal branches during hypoglossal nerve stimulator implantation: Clinical outcomes of twenty patients at a single institution 1 
| INTRODUCTION
Obstructive sleep apnoea (OSA) is a sleep disorder caused by complete or partial obstruction of the upper airway causing episodes of apnoea. Untreated OSA is associated with increased risk of and worsening of hypertension, cardiovascular disease and metabolic abnormalities. The standard of care for treatment of OSA is continuous positive airway pressure (CPAP). However, approximately 50% report inability to achieve long-term adherence to CPAP. 1 Hypoglossal nerve stimulation (HNS) for the treatment of moderate to severe OSA in adults was approved by the Food and Drug Administration in April, 2014 . HNS has been shown to significantly improve respiratory events and as an effective second-line treatment for patients who were intolerant or unable to obtain benefit from CPAP. 2, 3 The Stimulation Treatment for Apnea Reduction (STAR)
trial proved the effectiveness of HNS in a prospective multicentre trial followed by a randomized therapy withdrawal trial. 4 In this manuscript, we report outcomes for 20 patients who underwent HNS at our institution using a modification of the previously described surgical technique with superior identification of the distal hypoglossal nerve. 5 
| MATERIALS AND METHODS

| Patient selection
The retrospective study examined 20 patients with OSA who underwent placement of HNS at one institution under a single surgeon.
The study was approved by our institutional review board. Implantation dates were from December 2015 to April 2017. Criteria for implantation included patients with moderate to severe OSA (apnoea-hypopnea index (AHI) >15 and <65) who could not tolerate CPAP treatment. Patients were excluded if there was significant central or mixed apnea (>25%). Pre-operative work-up also included completing the Epworth Sleepiness Scale (ESS), home or inpatient polysomnography (PSG) and a drug-induced sleep endoscopy (DISE).
| Surgical implantation
Patients who met the implant criteria underwent placement of the Inspire implantable HNS system (Inspire Medical Systems, Maple Grove, MN). A modification of the previously described technique is used to improve exposure of the distal hypoglossal nerve. 5 The hypoglossal nerve is dissected anteriorly in the standard fashion.
Next, the mylohyoid muscle is retracted off the hypoglossal nerve and approximately 2.0 cm of the posterior mylohyoid muscle is transected to improve exposure to the distal hypoglossal nerve (Figure 1A) . A self-retaining retractor is placed under the digastric tendon and mandible ramus to facilitate exposure and dissection of the distal nerve ( Figure 1B) . A nerve integrity monitoring (NIM) system is used for precise selection of branches to be included in the cuff electrode. A bipolar nerve stimulator is used to help differentiate protractor (inclusion) branches from retractor (exclusion)
branches. The cuff of the implantable pulse generator device is placed around all inclusion branches, which included the first cervical nerve (C1) branch to geniohyoid if possible ( Figure 1C ).
| Post-operative evaluation
The patients were seen post-operatively at 1 week and at routine 
| Data collection
We examined medical records through the institution's electronic • We utilised a modification in standard surgical technique allowing improved visualisation of the distal hypoglossal nerve.
• Main outcome and measures included apnea-hypoxia index, oxygen desaturation index, mean and minimum saturation and percentage of time below 90% saturation.
We examined operative time and adverse events.
Epworth Sleepiness Score and post-operative questionnaires were used to assess subjective measures of outcome.
• Our outcomes favourably compare to previously reported HNS outcomes and highlights the importance of optimal visualisation of the hypoglossal nerve distal branches. 
| Surgical implantation
The device was implanted successfully in all 20 subjects, with a mean surgical implant time of 115 minutes (range, 88-150 minutes).
One patient had an immediate post-operative neck haematoma. One temporary marginal mandibular weakness was observed. None of the patients had any temporary or permanent hypoglossal nerve weakness. 
| Post-implant characteristics
| Post-implant subjective characteristics
The post-implant ESS and PET questionnaire were performed in all 20
subjects. There was a statistically significant decrease in ESS score by 4.9 (95% CI 2.45, 7.45) with a mean ESS of 6 following implantation ( Figure 2C ). The results from the PET can be seen in Figure 3 . The hypoglossal nerve innervates multiple muscles of the tongue including the retractors (styloglossus, hyoglossus), protrusions (genioglossus, horizontal and oblique) and stiffeners (transverse and vertical). 8, 9 There are reports of the utility of nerve monitoring to create a more selective upper-airway stimulation system by separating the inclusion and exclusion branches. hyoglossal muscle nerve branches. These branches can be embedded in the main nerve, and therefore easily overlooked, especially when they course beyond the anterior border of the hyoglossus muscle prior to arcing superiorly from the distal main trunk. By partially splitting the mylohyoid muscle, the exposure to the distal hypoglossal nerve becomes significantly easier, avoiding distal hypoglossal nerve dissection through a "tunnel". This superior exposure allows the surgeon to visualise these, at times, very small and embedded exclusion branches rather than solely trusting the NIMS signals. This approach allows for consistently correct cuff placement and selective protractor muscle stimulation. Further, the improved exposure may reduce the amount of hypoglossal nerve manipulation needed for cuff placement reducing the risk for stretch injury. None of the patients in our series had any post-operative tongue weakness.
| CONCLUSION
There are limitations in our study including the lack of a control comparison between patients who underwent the traditional surgical approach compared to our approach. Despite this, our clinical outcomes are comparable to previously reported outcomes of HNS. Our study provides further evidence regarding the safety and efficacy of HNS for OSA and highlights the importance of exposure of the distal hypoglossal nerve for optimising therapeutic outcome.
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